Online: | |
Visits: | |
Stories: |
Story Views | |
Now: | |
Last Hour: | |
Last 24 Hours: | |
Total: |
It wasn’t long ago that a group of federal researchers commissioned by the United States government discovered that the two most common cannabinoids in marijuana, tetrahydrocannabinol (THC) and cannabidiol (CBD), weaken the ferocity of cancer cells and render them more susceptible to radiation treatment. This marked a major shift in the federal stance on cannabis, particularly since, historically, the US government and other major medical health bodies (like the CDC) have refused to admit that cannabis has any medicinal properties whatsoever.
But it has been clear for years that this is not the case. Whether in combination with chemotherapy or used alone, many people have already taken the leap and found success treating cancer with cannabis, and decades of research now irrefutably show that THC and CBD completely destroy cancer cells. Hundreds (if not thousands) of studies have been published clearly demonstrating this, yet no clinical trials have been funded or initiated to try to replicate these results in an actual human being with cancer.
Only recently have we seen such trials take place, and only ever in conjunction with chemotherapy drugs, which is a shame. I think we have a long way to go before the federal research that really needs funding — clinical trials of cannabis alone — will happen. Decades of research have already shown that cannabis destroys cancer cells, and a simple Google search will yield you plenty of results which support this. The justification for clinical trials has been there for years.
Sadly, if a pharmaceutical drug were to show even half the medicinal promise that cannabis already does, it would be tested in clinical trials immediately. This is the reality of the pharmaceutical industry. Plants are simply not profitable.
Philosophers stone – selected views from the boat http://philosophers-stone.co.uk